Carregant...
Potential Roles for PD‐1 Inhibition and Cabozantinib in Patients with Metastatic Non‐Clear Cell Renal Cell Carcinoma
This commentary discusses studies in metastatic non‐clear cell renal cell carcinoma and provides suggestions for choosing between treatment with nivolumab and treatment with cabozantinib.
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7066721/ https://ncbi.nlm.nih.gov/pubmed/32162830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0657 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|